Replies to post #190830 on NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

And Mark Lowdell is also a Consultant to NWBO.

He was at the NWBO presentation at ASCO, by the way.

He is the qualified person at CCGTT which is the largest CGT in London, which hold the manufacturing licenses, under which Advent produce DCVaxL for the UK Specials scheme.
He routinely deals with regulators.

Good man to know (as I've posted previously, along with your links!)

No harm in a bit of reiteration, in this case.

[exwannabe]

Yes, I did here him talk about optimizing the manufacturing process for cellular products.

What I heard talk about was the importance of getting it right prior to or in the P2. So they have the final process prior to starting the P3, because once the P3 is underway the process is "locked down" as that will be the process licensed for marketing.

Did not hear him talk about optimizing the manufacturing process late in the P3.